• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人前列腺癌细胞中的表皮生长因子受体(ErbB)激酶与神经分化因子(NDF)信号传导

ErbB kinases and NDF signaling in human prostate cancer cells.

作者信息

Grasso A W, Wen D, Miller C M, Rhim J S, Pretlow T G, Kung H J

机构信息

Case Western Reserve University School of Medicine, Department of Molecular Biology and Microbiology, Cleveland, Ohio 44106-4960, USA.

出版信息

Oncogene. 1997 Nov 27;15(22):2705-16. doi: 10.1038/sj.onc.1201447.

DOI:10.1038/sj.onc.1201447
PMID:9400997
Abstract

Prostate carcinoma (PCA) is the most commonly diagnosed malignancy in American men. Our knowledge of PCA growth regulation lags behind that of other cancers, such as breast and colon carcinomas. Among receptor tyrosine kinases, the ErbB family is most frequently implicated in neoplasia. We report here the expression of ErbB family kinases and their ligands in PCA cell lines and a xenograft. While ErbB1/EGFR, ErbB2/NEU, and ErbB3 were always observed in a distinct pattern, ErbB4 was not observed. Interestingly, while TGF-alpha was expressed in the majority of PCA lines, the ligand Neu Differentiation Factor/Heregulin (NDF) was expressed only in an immortalized, non-transformed prostate epithelial line. Concomitantly, there was a significant difference in biological response to these ligands. NDF inhibited LNCaP growth and induced an epithelial-like morphological change, in contrast to TGF-alpha, which accelerated cell growth. We also performed the first comprehensive analysis of NDF signaling in a prostate line. LNCaP stimulated with NDF demonstrated crosstalk between ErbB3 and ErbB2 which did not involve ErbB1. NDF also turned on several cascades, including those of PI3-K, ERK/MAPK, mHOG/p38 and JNK/SAPK, but not those of PLCgamma or the STAT family. This signaling pattern is distinct from that of TGF-alpha. The activation of mHOG by ErbB2 or ErbB3 has not been reported, and may contribute to the unusual phenotype. PI3-K activation is characterized by the formation of a striking 'activation complex' with multiple tyrosine-phosphorylated species, including ErbB3. Our studies provide a framework in which to dissect the growth and differentiation signals of prostate cancer cells.

摘要

前列腺癌(PCA)是美国男性中最常被诊断出的恶性肿瘤。我们对PCA生长调控的了解落后于其他癌症,如乳腺癌和结肠癌。在受体酪氨酸激酶中,ErbB家族最常与肿瘤形成有关。我们在此报告ErbB家族激酶及其配体在PCA细胞系和异种移植中的表达情况。虽然总是以独特模式观察到ErbB1/表皮生长因子受体(EGFR)、ErbB2/神经表皮生长因子受体(NEU)和ErbB3,但未观察到ErbB4。有趣的是,虽然大多数PCA细胞系中都表达转化生长因子-α(TGF-α),但配体神经分化因子/神经调节蛋白(NDF)仅在永生化、未转化的前列腺上皮细胞系中表达。同时,对这些配体的生物学反应存在显著差异。与加速细胞生长的TGF-α相反,NDF抑制LNCaP细胞生长并诱导上皮样形态变化。我们还对前列腺细胞系中的NDF信号传导进行了首次全面分析。用NDF刺激的LNCaP细胞显示出ErbB3和ErbB2之间的相互作用,其中不涉及ErbB1。NDF还激活了几个信号级联反应,包括磷脂酰肌醇-3激酶(PI3-K)、细胞外信号调节激酶/丝裂原活化蛋白激酶(ERK/MAPK)、丝裂原活化蛋白激酶激酶/ p38(mHOG/p38)和应激活化蛋白激酶/ c-Jun氨基末端激酶(JNK/SAPK)的信号级联反应,但不包括磷脂酶Cγ(PLCγ)或信号转导和转录激活因子(STAT)家族的信号级联反应。这种信号传导模式与TGF-α不同。ErbB2或ErbB3激活mHOG的情况尚未见报道,这可能导致了这种异常表型。PI3-K的激活特征是形成一个由多个酪氨酸磷酸化物种组成的显著“激活复合物”,包括ErbB3。我们的研究提供了一个剖析前列腺癌细胞生长和分化信号的框架。

相似文献

1
ErbB kinases and NDF signaling in human prostate cancer cells.人前列腺癌细胞中的表皮生长因子受体(ErbB)激酶与神经分化因子(NDF)信号传导
Oncogene. 1997 Nov 27;15(22):2705-16. doi: 10.1038/sj.onc.1201447.
2
NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.NDF/神经调节蛋白诱导的乳腺肿瘤细胞周期变化及凋亡:PI3激酶和p38丝裂原活化蛋白激酶信号通路的作用
Oncogene. 1999 Jun 10;18(23):3440-51. doi: 10.1038/sj.onc.1202700.
3
Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.神经分化因子/神经调节蛋白及其受体复合物在前列腺癌中的组织表达及其对前列腺癌细胞的体外生物学效应
Cancer J Sci Am. 1997 Jan-Feb;3(1):21-30.
4
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.表皮生长因子和β细胞素通过共同表达的ErbB2和ErbB3受体介导信号转导。
EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608.
5
Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.在有丝分裂期间,神经分化因子/神经调节蛋白可有效诱导p185erbB - 2和erbB - 3募集磷脂酰肌醇3 -激酶,并且在具有c - erbB - 2基因扩增的不依赖生长因子的乳腺癌细胞中,该过程持续增强。
Cell Growth Differ. 1996 May;7(5):551-61.
6
Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.赫赛汀β1激活的磷脂酰肌醇3激酶增强MCF-7乳腺癌细胞的聚集,且不依赖于细胞外信号调节激酶。
Cancer Res. 1999 Apr 1;59(7):1620-5.
7
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.神经分化因子(Heregulin)激活癌细胞中一种依赖p53的信号通路。
Oncogene. 1996 Jun 20;12(12):2535-47.
8
Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration.转化生长因子α对细胞外信号调节激酶、磷脂酰肌醇3激酶和磷脂酶Cγ途径的刺激在卵巢癌生长和迁移中的作用
Exp Cell Res. 2005 Mar 10;304(1):305-16. doi: 10.1016/j.yexcr.2004.11.007. Epub 2004 Dec 9.
9
Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.ErbB3与ErbB2在肿瘤转化及人类乳腺癌中的协同信号传导
Oncogene. 1995 May 4;10(9):1813-21.
10
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.表皮生长因子相关肽的可获得性会影响表皮生长因子受体靶向抗癌疗法的疗效。
Cancer Res. 2002 Jun 1;62(11):3151-8.

引用本文的文献

1
Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localization.氨氯吡咪通过调节Erbb3亚细胞定位,使前列腺癌细胞对可逆性酪氨酸激酶抑制剂拉帕替尼敏感。
Cell Mol Life Sci. 2024 Dec 27;82(1):24. doi: 10.1007/s00018-024-05540-5.
2
Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization.氨氯吡咪通过调节ERBB3亚细胞定位使前列腺癌细胞对可逆性酪氨酸激酶抑制剂拉帕替尼敏感。
Res Sq. 2024 Aug 30:rs.3.rs-4844371. doi: 10.21203/rs.3.rs-4844371/v1.
3
Androgen Signaling in Prostate Cancer: When a Friend Turns Foe.
前列腺癌中的雄激素信号传导:当朋友变成敌人时。
Endocr Metab Immune Disord Drug Targets. 2025;25(1):37-56. doi: 10.2174/0118715303313528240523101940.
4
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.ERBB4 的阴阳两面:肿瘤抑制蛋白和癌蛋白。
Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381.
5
Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication.新城疫病毒感染的HeLa细胞中微小RNA的差异表达及其在调节病毒复制中的作用。
Front Oncol. 2021 Jun 4;11:616809. doi: 10.3389/fonc.2021.616809. eCollection 2021.
6
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion.使用深度学习模型和相似性网络融合通过多组学数据分析进行前列腺癌预后生物标志物识别
Cancers (Basel). 2021 May 21;13(11):2528. doi: 10.3390/cancers13112528.
7
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase.达可替尼抑制了 HER2 的增加,从而抑制了去势抵抗性前列腺癌模型的进展,但拉帕替尼没有。
Br J Cancer. 2019 Jul;121(3):237-248. doi: 10.1038/s41416-019-0496-4. Epub 2019 Jun 18.
8
Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.基于影像引导的光热治疗卟啉与热休克蛋白 90 抑制剂协同作用于患者来源的膀胱癌异种移植模型。
Nanomedicine. 2018 Apr;14(3):789-799. doi: 10.1016/j.nano.2017.12.014. Epub 2018 Jan 6.
9
HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy.载 HSP90 抑制剂的光热诊疗一体化纳米粒用于协同组合癌症治疗。
Theranostics. 2016 Jun 7;6(9):1324-35. doi: 10.7150/thno.14882. eCollection 2016.
10
Integrated and Functional Genomics Analysis Validates the Relevance of the Nuclear Variant ErbB380kDa in Prostate Cancer Progression.整合与功能基因组学分析验证了核变异体ErbB380kDa在前列腺癌进展中的相关性。
PLoS One. 2016 May 18;11(5):e0155950. doi: 10.1371/journal.pone.0155950. eCollection 2016.